Monday, January 25, 2021

LATEST ARTICLES

FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs

January 11, 2021: "The U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of...

Promising new treatment strategy for men with drug-resistant prostate cancer

January 12, 2020: "A new experimental drug could offer a promising approach to treating men with advanced prostate cancer which does not...

Biogen to launch pioneering study with Apple watch and iphone

January 11, 2021: "Biogen Inc. announced a new virtual research study, in collaboration with Apple, to investigate the role Apple Watch and iPhone...

Sanofi to acquire Kymab for up to $1.45billion

January 11, 2021: "Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and...

Boehringer Ingelheim’s Partnership with Google for Pharma R&D

January 11th, 2021: Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use...

Roche’s Xofluza approved by the EU for the treatment of influenza

January 11, 2021: "Roche announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) for the treatment of uncomplicated influenza in...

FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff

January 08, 2021: "The U.S. Food and Drug Administration is alerting clinical laboratory staff and health care providers that the FDA is...

Lifearc funds Covid-19 drug screening hub at the University of Glasgow

Jan 06, 2021: "A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow...

FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines

January 04, 2021: "Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease in adults.

Allergy Therapeutics begins peanut allergy vaccine study

January 05, 2021: "Speciality allergy-focussed pharmaceutical company Allergy Therapeutics announced on Tuesday that an ex-vivo biomarker study of blood samples from peanut allergy patients...

AZ’s Farxiga granted Priority Review in US for chronic kidney disease

January 06, 2021: "AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney disease...

AstraZeneca’s COVID-19 vaccine authorised in five other countries

January 06, 2021: AstraZeneca’s COVID-19 vaccinehas been granted emergency use authorisation in India as well as Argentina, Dominican Republic, El Salvador, Mexico...

Other

What is the process for Submission of Synopsis?

1.1 a. "Prior to submission of a thesis synopsis, a comprehensive assessment of the research work should be carried out by a...

What Is a Synopsis? What is the Process for Submission of Synopsis?

"A synopsis is a brief summary that gives audiences an idea of what a composition is all about. The...

What Is a Blockbuster Drug?

What Is a Blockbuster Drug? "Blockbuster drugs are those that generate at least $1 billion of revenue per...

Covaxin: Everything that you should know

Covaxin is an investigational vaccine candidate for COVID19. It is in Phase III clinical trial as of today (20-Dec-2020). It is being...